Regulation of the CD4+ T cell allo-immune response by endothelial cells

Human Immunology

Volumn 73, Issue 12, 2012, Pages 1269-1274

  Taflin, Cécile ^a,b,c   Charron, Dominique ^a,b   Glotz, Denis ^a,b,c   Mooney, Nuala ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CD4 ANTIGEN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; OX40 LIGAND; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; VASCULAR CELL ADHESION MOLECULE 1;

ALLOIMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CYTOKINE RELEASE; EFFECTOR CELL; ENDOTHELIUM CELL; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; TRANSPLANTATION TOLERANCE; VASCULAR ENDOTHELIUM;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENDOTHELIAL CELLS; GRAFT REJECTION; HUMANS; ISOANTIBODIES; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84869086456     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.009     Document Type: Article

References (65)

1. Sellares J., de Freitas D.G., Mengel M., Reeve J., Einecke G., Sis B., et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012, 12:388-399.
2. Brouard S., Renaudin K., Soulillou J.P. Revisiting the natural history of IF/TA in renal transplantation. Am J Transplant 2011, 11:647-649.
3. Cosio F.G., Gloor J.M., Sethi S., Stegall M.D. Transplant glomerulopathy. Am J Transplant 2008, 8:492-496.
4. Vora M., Yssel H., de Vries J.E., Karasek M.A. Antigen presentation by human dermal microvascular endothelial cells. Immunoregulatory effect of IFN-gamma and IL-10. J Immunol 1994, 152:5734-5741.
5. Muczynski K.A., Ekle D.M., Coder D.M., Anderson S.K. Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol 2003, 14:1336-1348.
6. Manes T.D., Shiao S.L., Dengler T.J., Pober J.S. TCR signaling antagonizes rapid IP-10-mediated transendothelial migration of effector memory CD4+ T cells. J Immunol 2007, 178:3237-3243.
7. Shiao S.L., McNiff J.M., Pober J.S. Memory T cells and their costimulators in human allograft injury. J Immunol 2005, 175:4886-4896.
8. Rao D.A., Eid R.E., Qin L., Yi T., Kirkiles-Smith N.C., Tellides G., et al. Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. J Exp Med 2008, 205:3145-3158.
9. Krupnick A.S., Gelman A.E., Barchet W., Richardson S., Kreisel F.H., Turka L.A., et al. Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol 2005, 175:6265-6270.
10. Taflin C., Charron D., Glotz D., Mooney N. Immunological function of the endothelial cell within the setting of organ transplantation. Immunol Lett 2011, 139:1-6.
11. Brewer Y., Palmer A., Taube D., Welsh K., Bewick M., Bindon C., et al. Effect of graft perfusion with two CD45 monoclonal antibodies on incidence of kidney allograft rejection. Lancet 1989, 2:935-937.
12. Kreisel D., Krupnick A.S., Balsara K.R., Riha M., Gelman A.E., Popma S.H., et al. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J Immunol 2002, 169:6154-6161.
13. Epperson D.E., Pober J.S. Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells. J Immunol 1994, 153:5402-5412.
14. Kreisel D., Krasinskas A.M., Krupnick A.S., Gelman A.E., Balsara K.R., Popma S.H., et al. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection. J Immunol 2004, 173:3027-3034.
15. Grazia T.J., Pietra B.A., Johnson Z.A., Kelly B.P., Plenter R.J., Gill R.G. A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J Immunol 2004, 172:7451-7458.
16. Taflin C., Favier B., Baudhuin J., Savenay A., Hemon P., Bensussan A., et al. Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions. Proc Natl Acad Sci USA 2011, 108:2891-2896.
17. Marelli-Berg F.M., Hargreaves R.E., Carmichael P., Dorling A., Lombardi G., Lechler R.I. Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med 1996, 183:1603-1612.
18. Hughes C.C., Savage C.O., Pober J.S. Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J Exp Med 1990, 171:1453-1467.
19. McDouall R.M., Yacoub M., Rose M.L. Isolation, culture, and characterisation of MHC class II-positive microvascular endothelial cells from the human heart. Microvasc Res 1996, 51:137-152.
20. Mestas J., Hughes C.C. Endothelial cell costimulation of T cell activation through CD58-CD2 interactions involves lipid raft aggregation. J Immunol 2001, 167:4378-4385.
21. Kunitomi A., Hori T., Imura A., Uchiyama T. Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system. J Leukoc Biol 2000, 68:111-118.
22. Khayyamian S., Hutloff A., Buchner K., Grafe M., Henn V., Kroczek R.A., et al. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci USA 2002, 99:6198-6203.
23. Drenkard D., Becke F.M., Langstein J., Spruss T., Kunz-Schughart L.A., Tan T.E., et al. CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. FASEB J 2007, 21:456-463.
24. Waaga A.M., Gasser M., Kist-van Holthe J.E., Najafian N., Muller A., Vella J.P., et al. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest 2001, 107:909-916.
25. Yuan X., Paez-Cortez J., Schmitt-Knosalla I., D'Addio F., Mfarrej B., Donnarumma M., et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008, 205:3133-3144.
26. Van Kooten C., Boonstra J.G., Paape M.E., Fossiez F., Banchereau J., Lebecque S., et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 1998, 9:1526-1534.
27. Hsieh H.G., Loong C.C., Lin C.Y. Interleukin-17 induces src/MAPK cascades activation in human renal epithelial cells. Cytokine 2002, 19:159-174.
28. Fabrega E., Lopez-Hoyos M., San Segundo D., Casafont F., Benito M.J., Pons-Romero F. Effect of immunosuppressant blood levels on serum concentration of interleukin-17 and -23 in stable liver transplant recipients. Transplant Proc 2009, 41:1025-1027.
29. Vanaudenaerde B.M., Wuyts W.A., Geudens N., Dupont L.J., Schoofs K., Smeets S., et al. Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant 2007, 7:76-82.
30. Taylor P.A., Noelle R.J., Blazar B.R. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001, 193:1311-1318.
31. Kingsley C.I., Karim M., Bushell A.R., Wood K.J. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002, 168:1080-1086.
32. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003, 3:199-210.
33. Bestard O., Cruzado J.M., Rama I., Torras J., Goma M., Seron D., et al. Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008, 19:2020-2026.
34. Bestard O., Cruzado J.M., Mestre M., Caldes A., Bas J., Carrera M., et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 2007, 179:4901-4909.
35. Mansour H., Homs S., Desvaux D., Badoual C., Dahan K., Matignon M., et al. Intragraft levels of Foxp3 mRNA predict progression in renal transplants with borderline change. J Am Soc Nephrol 2008, 19:2277-2281.
36. Taflin C., Nochy D., Hill G., Frouget T., Rioux N., Verine J., et al. Regulatory T cells in kidney allograft infiltrates correlate with initial inflammation and graft function. Transplantation 2010, 89:194-199.
37. Mazanet M.M., Hughes C.C. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol 2002, 169:3581-3588.
38. Rodig N., Ryan T., Allen J.A., Pang H., Grabie N., Chernova T., et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 2003, 33:3117-3126.
39. Thebault P., Condamine T., Heslan M., Hill M., Bernard I., Saoudi A., et al. Role of IFNgamma in allograft tolerance mediated by CD4+CD25+ regulatory T cells by induction of IDO in endothelial cells. Am J Transplant 2007, 7:2472-2482.
40. Beutelspacher S.C., Pillai R., Watson M.P., Tan P.H., Tsang J., McClure M.O., et al. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 2006, 36:690-700.
41. Baecher-Allan C., Wolf E., Hafler D.A. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006, 176:4622-4631.
42. Baecher-Allan C.M., Costantino C.M., Cvetanovich G.L., Ashley C.W., Beriou G., Dominguez-Villar M., et al. CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis. J Immunol 2011, 186:3317-3326.
43. Manes T.D., Pober J.S. Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4+ T cells. J Immunol 2008, 180:8386-8392.
44. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7:678-689.
45. Fogal B., Yi T., Wang C., Rao D.A., Lebastchi A., Kulkarni S., et al. Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells. J Immunol 2011, 187:6268-6280.
46. Zhao X., Boenisch O., Yeung M., Mfarrej B., Yang S., Turka L.A., et al. Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am J Transplant 2012, 12:90-101.
47. Onishi Y., Fehervari Z., Yamaguchi T., Sakaguchi S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA 2008, 105:10113-10118.
48. Marski M., Kandula S., Turner J.R., Abraham C. CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells. J Immunol 2005, 175:7889-7897.
49. Tran D.Q., Glass D.D., Uzel G., Darnell D.A., Spalding C., Holland S.M., et al. Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function. J Immunol 2009, 182:2929-2938.
50. Wohler J., Bullard D., Schoeb T., Barnum S. LFA-1 is critical for regulatory T cell homeostasis and function. Mol Immunol 2009, 46:2424-2428.
51. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 1994, 265:106-109.
52. Kluger M.S., Johnson D.R., Pober J.S. Mechanism of sustained E-selectin expression in cultured human dermal microvascular endothelial cells. J Immunol 1997, 158:887-896.
53. Swerlick R.A., Lee K.H., Wick T.M., Lawley T.J. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 1992, 148:78-83.
54. Loppnow H., Libby P. Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1. Cell Immunol 1989, 122:493-503.
55. Fitzner N., Clauberg S., Essmann F., Liebmann J., Kolb-Bachofen V. Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands. Clin Vaccine Immunol 2008, 15:138-146.
56. Cromer W.E., Mathis J.M., Granger D.N., Chaitanya G.V., Alexander J.S. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol 2011, 17:578-593.
57. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007, 81:1-5.
58. Andrassy M., Volz H.C., Igwe J.C., Funke B., Eichberger S.N., Kaya Z., et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008, 117:3216-3226.
59. Shirali A.C., Goldstein D.R. Activation of the innate immune system by the endogenous ligand hyaluronan. Curr Opin Organ Transplant 2008, 13:20-25.
60. Zou N., Ao L., Cleveland J.C., Yang X., Su X., Cai G.Y., et al. Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2008, 294:H2805-2813.
61. Zhang H., Wada J., Nanba K., Kunitomi M., Hida K., Nagake Y., et al. Familial interstitial nephritis with progressive renal failure. Am J Kidney Dis 2000, 36:E25.
62. Smith J.D., Lawson C., Yacoub M.H., Rose M.L. Activation of NF-kappa B in human endothelial cells induced by monoclonal and allospecific HLA antibodies. Int Immunol 2000, 12:563-571.
63. Reyes-Vargas E., Pavlov I.Y., Martins T.B., Schwartz J.J., Hill H.R., Delgado J.C. Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern. J Clin Lab Anal 2009, 23:157-160.
64. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
65. Herrath J., Muller M., Amoudruz P., Janson P., Michaelsson J., Larsson P.T., et al. The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function. Eur J Immunol 2011, 41:2279-2290.